Cart 0 Product Products (empty)
No products
To be determined Shipping
0,00 € Total
Prices are tax excluded
Product successfully added to your shopping cart
Quantity
Total
There are 0 items in your cart. There is 1 item in your cart.
Total products (tax excl.)
Total shipping (tax excl.) To be determined
Total (tax excl.)
Data sheet of RNF103 polyclonal antibody
| Brand | Abnova |
| Product type | Primary antibodies |
| Host species | Goat |
| Applications | ELISA |
More info about RNF103 polyclonal antibody
| Brand: | Abnova |
| Reference: | PAB6394 |
| Product name: | RNF103 polyclonal antibody |
| Product description: | Goat polyclonal antibody raised against synthetic peptide of RNF103. |
| Gene id: | 7844 |
| Gene name: | RNF103 |
| Gene alias: | KF1|MGC102815|MGC41857|ZFP103|hkf-1 |
| Gene description: | ring finger protein 103 |
| Immunogen: | A synthetic peptide corresponding to human RNF103. |
| Immunogen sequence/protein sequence: | C-YAQHQPLSNDVPS |
| Protein accession: | NP_005658 |
| Form: | Liquid |
| Concentration: | 0.5 mg/mL |
| Recommend dilutions: | ELISA (1:8000) The optimal working dilution should be determined by the end user. |
| Storage buffer: | In Tris saline, pH 7.3 (0.5% BSA, 0.02% sodium azide) |
| Storage instruction: | Store at -20°C. Aliquot to avoid repeated freezing and thawing. |
| Quality control testing: | Antibody Reactive Against Synthetic Peptide. |
| Note: | This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only. |
| Product type: | Primary antibodies |
| Host species: | Goat |
| Antigen species / target species: | Human |
| Applications: | ELISA |
| Shipping condition: | Dry Ice |
| Publications: | Cloning of human and mouse cDNAs encoding novel zinc finger proteins expressed in cerebellum and hippocampus.Yasojima K, Tsujimura A, Mizuno T, Shigeyoshi Y, Inazawa J, Kikuno R, Kuma K, Ohkubo K, Hosokawa Y, Ibata Y, Abe T, Miyata T, Matsubara K, Nakajima K, Hashimoto-Gotoh T. Biochem Biophys Res Commun. 1997 Feb 13;231(2):481-7. |